[144] CompoSecure, Inc. SEC Filing

Rhea-AI Filing Summary

CompoSecure, Inc. (CMPO) submitted a Form 144 notice for a proposed sale of 97,226 shares of Class A common stock, to be handled by Merrill Lynch (225 Liberty St, Floor 37, New York). The filing reports an aggregate market value of $1,881,980.97 and shows 102,378,638 shares outstanding. The securities were acquired and are being sold following a broker-assisted exercise of employee stock options on 08/14/2025. The filing also discloses a recent sale by Gregoire Maes of 19,899 shares on 08/13/2025 for $383,293.75. The signer represents no undisclosed material adverse information exists regarding the issuer.

Positive

• Transparent disclosure of the proposed sale including broker, share count, market value, and dates
• Acquisition and sale method disclosed (broker-assisted exercise of employee stock options) which clarifies transaction nature

Negative

• Insider sale increases available shares for trading, which may affect perceived insider conviction
• No additional issuer context provided (no financials or rationale), limiting assessment of materiality beyond the transaction details

Insights

Securities Analyst

TL;DR: Insider exercised options and filed to sell 97,226 shares via Merrill Lynch; disclosure is routine but relevant to share supply.

The Form 144 shows an employee stock option exercise and immediate proposed sale of 97,226 Class A shares with an aggregate market value of $1,881,980.97. The filing provides counterparties and dates, and notes a prior sale by Gregoire Maes of 19,899 shares for $383,293.75. This is a standard Rule 144 disclosure that increases available free float for the issuer on the noted sale date but contains no financial performance data or new operational facts.

Corporate Governance Expert

TL;DR: The notice documents compliant insider disposition after option exercise; governance disclosure obligations appear met.

The filer discloses acquisition via employee stock option exercise and a broker-assisted sale process, with explicit dates and amounts. The representation that no material nonpublic information is known by the seller is included. The form contains required signature and certification language; it does not report any governance actions, related-party transfers beyond the exercise, or plans that would imply unusual insider conduct.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	Merrill Lynch 225 Liberty St Floor 37 New York NY 10281	97226	1881980.97	102378638	08/14/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	08/14/2025	Exercise of employee stock options	CompoSecure, Inc.			97226	08/14/2025	Broker assisted exercise of employee stock options

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Gregoire Maes 309 PIERCE STREET SOMERSET NJ 08873	Class A Common Stock	08/13/2025	19899	383293.75

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did CompoSecure (CMPO) report on Form 144?

The filing notifies a proposed sale of 97,226 Class A common shares with an aggregate market value of $1,881,980.97, to be executed by Merrill Lynch on 08/14/2025.

How were the 97,226 shares acquired according to the filing?

The shares were acquired on 08/14/2025 via exercise of employee stock options, with a broker-assisted exercise noted.

Did the filing disclose any recent related sales?

Yes. The filing shows Gregoire Maes sold 19,899 Class A shares on 08/13/2025 for $383,293.75.

Who is the broker handling the proposed sale?

The broker named is Merrill Lynch at 225 Liberty St, Floor 37, New York, NY 10281.

Does the filer assert any undisclosed material information about the issuer?

The filer represents by signature that they do not know any material adverse information regarding the issuer that has not been publicly disclosed.